# Alkis Togias

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alkis-togias/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,974 |
| Field | Asthma and respiratory diseases |
| h-index | 88 |
| i10-index | 239 |
| OpenAlex ID | https://openalex.org/A5063479502 |
| ORCID iD | https://orcid.org/0000-0001-9009-5717 |
| Works | 422 |

## Researcher papers

- [Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-2008/)
- [Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-guidelines-2016-revision/)
- [Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children](https://scholariq.org/papers/randomized-trial-of-omalizumab-anti-ige-for-asthma-in-inner-city-children/)
- [Rhinosinusitis: Establishing definitions for clinical research and patient care](https://scholariq.org/papers/rhinosinusitis-establishing-definitions-for-clinical-research-and-patient-care/)
- [Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs](https://scholariq.org/papers/allergic-rhinitis-and-its-impact-on-asthma-aria-achievements-in-10-years-and/)
- [Otolaryngology‐Head and Neck Surgery](https://scholariq.org/papers/otolaryngology-head-and-neck-surgery/)
- [Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations](https://scholariq.org/papers/preseasonal-treatment-with-either-omalizumab-or-an-inhaled-corticosteroid-boost/)
- [Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel](https://scholariq.org/papers/addendum-guidelines-for-the-prevention-of-peanut-allergy-in-the-united-states/)
- [Food allergy across the globe](https://scholariq.org/papers/food-allergy-across-the-globe/)
- [Sub-Lingual Immunotherapy](https://scholariq.org/papers/sub-lingual-immunotherapy/)
- [2019 ARIA Care pathways for allergen immunotherapy](https://scholariq.org/papers/2019-aria-care-pathways-for-allergen-immunotherapy/)

## Researcher topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Food Allergy and Anaphylaxis Research](https://scholariq.org/topics/food-allergy-and-anaphylaxis-research/)
- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)
- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.